Medical health screening services involve different types of medical tests performed to detect early signs of illness or other health problems. Screening tests are done when a person has no symptoms. Common medical screening tests include blood tests, imaging tests, genetic tests, and physical exams. Market Overview: Medical health screening services offer various advantages such as early detection of diseases, prevention and management of chronic illnesses, and improved health outcomes. Rising population susceptibility to various diseases and growing awareness about preventive healthcare are driving the demand for medical health screening services worldwide.
Market key trends:
Telehealth has emerged as one of the key trends in the medical health screening services market. It allows remote delivery of healthcare services such as disease screening and monitoring. During the COVID-19 pandemic, telehealth played a crucial role in facilitating access to screening services while maintaining social distancing. It enabled at-home sample collection and virtual consultations with healthcare providers. Going forward, increasing digitization in the healthcare industry and continual technological advancements are expected to further drive the adoption of telehealth-based screening models.
The global Medical Health Screening Services Market Demand is estimated to be valued at US$ 26.56 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Segment Analysis
The medical health screening services market is segmented into clinical Chemistry, hematology, microbiology,Immunology, coagaulation/hemostasis, and other segments. Among these, the clinical chemistry segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. Clinical chemistry screening tests assess the levels of substances in blood, urine, or other body fluids. They help diagnose various conditions like diabetes, kidney diseases, liver problems, and electrolyte imbalances. The wide application of clinical chemistry tests for screening of various metabolic and infectious diseases has driven the growth of this segment.
Key Takeaways
The global medical health screening services market is expected to witness high growth, exhibiting a CAGR of 5.5% over the forecast period, due to increasing prevalence of chronic diseases and rising awareness about preventive healthcare.
Regional analysis
North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. This can be attributed to factors such as high healthcare expenditure, availability of advanced medical health screening facilities, and rising awareness about preventive healthcare in the region. Asia Pacific is expected to exhibit the fastest growth during the forecast period due to growing medical tourism industry and rising healthcare expenditure in developing countries like China and India.
Key players
Key players operating in the medical health screening services market include Quest Diagnostics, Eurofins Scientific, SYNLAB International, Sonic Healthcare, LabCorp, Unilabs, Lifelabs, Healthscope, Clinical Reference Laboratory, and ACM Medical Laboratory. Quest Diagnostics is the market leader with strong brand presence across various countries. Eurofins Scientific offers a wide range of molecular testing for chronic diseases and food safety.
